Related Experiment Videos
[Studies on evodiamine induced HeLa cell apoptosis]
Xiao-fang Fei1, Ben-xiang Wang, Takashi Ikejima
1College of Life Sciences, Jilin University, Changchun 130023, China.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica
|February 6, 2003
Summary
Evodiamine inhibits HeLa cell growth by inducing apoptosis, a process partially dependent on the caspase-3 pathway. This study investigates the mechanism of evodiamine
Area of Science:
- Cell Biology
- Pharmacology
Background:
- Evodiamine is a natural alkaloid with potential anti-cancer properties.
- Understanding its mechanism of action is crucial for therapeutic development.
Purpose of the Study:
- To elucidate the mechanism by which evodiamine inhibits HeLa cell growth.
- To investigate the role of apoptosis and specific caspases in evodiamine-induced cell death.
Main Methods:
- HeLa cell viability assessed via crystal violet assay.
- Apoptosis induction evaluated through morphological changes (phase-contrast microscopy) and DNA fragmentation (agarose gel electrophoresis).
- Effect of caspase inhibitors (caspase-3 and caspase-1) on evodiamine-induced apoptosis.
Main Results:
- Evodiamine demonstrated dose- and time-dependent inhibition of HeLa cell growth.
- Evodiamine induced apoptosis in HeLa cells.
- Caspase-3 inhibitor partially blocked evodiamine-induced apoptosis, while caspase-1 inhibitor had no significant effect.
Conclusions:
- Evodiamine suppresses HeLa cell growth in vitro through apoptosis induction.
- The apoptotic process triggered by evodiamine is partially mediated by the caspase-3 pathway.
- Additional apoptotic pathways may also contribute to evodiamine's cytotoxic effects.